REVIEW : Overview of ALK and ROS1 Rearranged Lung Cancer

Many attempts have been made to find genetic abnormalities inducing carcinogenesis after the development of epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor targeting EGFR in lung cancer. New target therapies have been already commercialized and studied along with the recent discove...

Full description

Saved in:
Bibliographic Details
Published inTuberculosis and respiratory diseases Vol. 75; no. 6; pp. 236 - 237
Main Author Chang Min Choi
Format Journal Article
LanguageKorean
Published 대한결핵 및 호흡기학회 30.12.2013
Subjects
Anplastic Lymphoma Kinase
Human
Lung Neoplasms
ROS1 Protein
Online AccessGet full text

Cover

More Information
Summary:Many attempts have been made to find genetic abnormalities inducing carcinogenesis after the development of epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor targeting EGFR in lung cancer. New target therapies have been already commercialized and studied along with the recent discovery of gene rearrangement involved in the carcinogenic process of non-small cell lung cancer. This study aims to investigate anplastic lymphoma kinase, c-ros oncogene 1, and receptor tyrosine kinase, in particular.
Bibliography:The Korean Academy of Tuberculosis and Respiratory Diseases
ISSN:1738-3536
2005-6184